drugset / Trial / NCT03032965

Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation

NCT03032965

Phase 2 Completed 131 enrolled University of Michigan
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if additional ablation during the first procedure as the result of the ability to medically induce quiet atrial arrhythmias will improve clinical outcome in patients with atrial fibrillation thus decreasing the need for additional ablation procedures.

Timeline

Start
2011-10
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule Intravenous
Background Isoproterenol Small molecule Intravenous